Project Grant R21NS142817
- Federal Project Grant Award Summary Emory University received a $577,611 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective January 23, 2026, with completion targeted for December 31, 2030. The award supports fundamental neuroscience research investigating the cellular mechanisms underlying resting-state functional magnetic resonance...
- Federal Grant Award Summary Emory University received a $234,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2027. The research project focuses on developing instantaneous digital subtraction angiography technology for neurovascular applications to address cerebrovascular disease diagnosis and...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $470,293 through its Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Research Foundation For The State University Of New York (SUNY at Binghamton) for a two-year project period from July 1, 2025 through June 30, 2027. This Project Grant supports research to identify and characterize the electrophysiological features of spinal motor neurons...
- Federal Grant Award Summary Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 1, 2025 through June 30, 2027. The award supports fundamental and translational research investigating mechanisms of altered RNA (ribonucleic acid) transport dynamics caused by KIF1C (Kinesin Family Member 1C) mutations in...
- Federal Grant Award Summary Emory University received a $575,485 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 1, 2026, through January 31, 2031. This award supports fundamental neuroscience research investigating the neuronal function of BCL11A, a zinc-finger transcription factor implicated in intellectual disability, autism...
- Federal Grant Award Summary Drexel University received a $340,822 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of September 25, 2024, and completion date of November 30, 2026. The award funds investigator-initiated research focused on medial deep dorsal glycinergic interneurons as a therapeutic target to improve...
- Federal Project Grant Award Summary The University of Washington received a $427,625 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 21, 2025, with completion targeted for April 30, 2027. The award funds research to investigate whether electrical stimulation (ES) can enhance the therapeutic capacity of neural stem cell (STC)...
- Federal Grant Award Summary The University of Louisville's Office of Research & Innovation received a $591,304 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, issued on May 5, 2025, with a completion date of March 31, 2030, supports basic research investigating cell type-specific effects of the integrated stress response (ISR)...
- Federal Grant Award Summary Emory University received a $219,645 project grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 15, 2025, through July 31, 2030. This five-year career development research initiative focuses on identifying the role of T cells in anti-NMDA receptor encephalitis (NMDARE) in children, with specific emphasis on...
- Federal Grant Award Summary The University of Louisville's Office of Research & Innovation received a $462,296 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award, initiated on June 3, 2025, and scheduled for completion by May 31, 2030, funds basic neuroscience research investigating propriospinal plasticity and functional recovery...
Emory University received a $234,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, with an award date of January 26, 2026 and completion date of December 31, 2027. The grant funds research into neuromodulation of somato-sympathetic postganglionic neuron activity following spinal cord injury (SCI), with the objective of developing rigorous animal models using clinically analogous epidural spinal cord stimulation (SCS) to better understand autonomic function restoration after SCI and inform future clinical trials. The research deliverables include development and refinement of an in vivo approach incorporating modified microneurography techniques to record somatic sympathetic postganglionic neuron activity in mice, enabling simultaneous capture of sympathetic nerve activity from multiple hindlimb skin and muscle nerves. This investigator-initiated basic and translational research project addresses the significant clinical gap in understanding how electrotherapeutic strategies like SCS can improve dysautonomia symptoms in SCI patients, particularly concerning thermoregulation and muscle metabolic function impairment. The findings are intended to support evidence-based development of therapeutic protocols and advance clinical translation of autonomic neuromodulation strategies for spinal cord injury populations.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $234.8k | 1/26/26 |